Herbal capsule aims to tackle both high blood pressure and poor sleep

NCT ID NCT07709442

Not yet recruiting Disease control Sponsor: Jing Liu Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study investigates whether Songling Xuemaikang capsules, a traditional Chinese herbal formula, can help people with both high blood pressure (hypertension) and insomnia. About 260 adults aged 18–79 with mild hypertension and sleep difficulties will take either the herbal capsules or a placebo three times daily for 12 weeks. Researchers will measure changes in 24-hour blood pressure and sleep quality to see if the treatment offers dual benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Songling Xuemaikang capsules (a traditional Chinese medicine herbal formula)
What this could lead to
If successful, this could offer a new option for managing high blood pressure while also improving sleep quality.
What could go wrong
This is an early-stage study with a modest number of participants. The herbal formula may not prove more effective than placebo, and its long-term safety is not yet established.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peking University People's Hospital

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.